Shafer P, Kelly L, Hoyos V
Front Immunol. 2022; 13:835762.
PMID: 35309357
PMC: 8928448.
DOI: 10.3389/fimmu.2022.835762.
Zamora D, Duke E, Xie H, Edmison B, Akoto B, Kiener R
Blood. 2021; 138(1):34-43.
PMID: 33657225
PMC: 8493975.
DOI: 10.1182/blood.2020009396.
Xu Y, Morales A, Cargill M, Towlerton A, Coffey D, Warren E
Cancer Immunol Immunother. 2019; 68(12):1979-1993.
PMID: 31686124
PMC: 6877496.
DOI: 10.1007/s00262-019-02419-4.
Wong E, Gold M, Meermeier E, Xulu B, Khuzwayo S, Sullivan Z
Commun Biol. 2019; 2:203.
PMID: 31231693
PMC: 6549148.
DOI: 10.1038/s42003-019-0442-2.
Wagner E, Qerqez A, Stevens C, Nguyen A, Delidakis G, Maynard J
J Biol Chem. 2019; 294(15):5790-5804.
PMID: 30796163
PMC: 6463697.
DOI: 10.1074/jbc.RA118.007187.
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses.
Schmitt M, Schmitt A, Wiesneth M, Huckelhoven A, Wu Z, Kuball J
Theranostics. 2017; 7(6):1705-1718.
PMID: 28529646
PMC: 5436522.
DOI: 10.7150/thno.18301.
Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner.
Proff J, Walterskirchen C, Brey C, Geyeregger R, Full F, Ensser A
Front Microbiol. 2016; 7:844.
PMID: 27375569
PMC: 4899442.
DOI: 10.3389/fmicb.2016.00844.
Cell-mediated immunity to human CMV infection: a brief overview.
Terrazzini N, Kern F
F1000Prime Rep. 2014; 6:28.
PMID: 24860650
PMC: 4018181.
DOI: 10.12703/P6-28.
Impact of T cell selection methods in the success of clinical adoptive immunotherapy.
Ramirez N, Beloki L, Ciaurriz M, Rodriguez-Calvillo M, Escors D, Mansilla C
Cell Mol Life Sci. 2013; 71(7):1211-24.
PMID: 24077876
PMC: 11113470.
DOI: 10.1007/s00018-013-1463-5.
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.
Hansen S, Sacha J, Hughes C, Ford J, Burwitz B, Scholz I
Science. 2013; 340(6135):1237874.
PMID: 23704576
PMC: 3816976.
DOI: 10.1126/science.1237874.
Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells.
Kloverpris H, Payne R, Sacha J, Rasaiyaah J, Chen F, Takiguchi M
J Virol. 2012; 87(5):2628-38.
PMID: 23255798
PMC: 3571362.
DOI: 10.1128/JVI.02131-12.
CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model.
Tykodi S, Satoh S, Deming J, Chou J, Harrop R, Warren E
J Immunother. 2012; 35(7):523-33.
PMID: 22892449
PMC: 3423552.
DOI: 10.1097/CJI.0b013e318261d630.
Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.
Ochsenreither S, Majeti R, Schmitt T, Stirewalt D, Keilholz U, Loeb K
Blood. 2012; 119(23):5492-501.
PMID: 22529286
PMC: 3369684.
DOI: 10.1182/blood-2011-07-365890.
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells.
Terakura S, Yamamoto T, Gardner R, Turtle C, Jensen M, Riddell S
Blood. 2011; 119(1):72-82.
PMID: 22031866
PMC: 3251238.
DOI: 10.1182/blood-2011-07-366419.
A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.
Berger C, Berger M, Anderson D, Riddell S
J Med Primatol. 2010; 40(2):88-103.
PMID: 21044089
PMC: 3048898.
DOI: 10.1111/j.1600-0684.2010.00451.x.
Simian immunodeficiency virus-specific CD8+ T cells recognize Vpr- and Rev-derived epitopes early after infection.
Sacha J, Buechler M, Newman L, Reed J, Wallace L, Loffredo J
J Virol. 2010; 84(20):10907-12.
PMID: 20686015
PMC: 2950557.
DOI: 10.1128/JVI.01357-10.
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.
Bleakley M, Otterud B, Richardt J, Mollerup A, Hudecek M, Nishida T
Blood. 2010; 115(23):4923-33.
PMID: 20203263
PMC: 2890170.
DOI: 10.1182/blood-2009-12-260539.
Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method.
Ogbomo H, Geiler J, Leutz A, von Kietzell K, Michaelis M, Doerr H
Med Microbiol Immunol. 2009; 198(4):257-62.
PMID: 19813020
DOI: 10.1007/s00430-009-0126-5.
Treatment of lymphoma with adoptively transferred T cells.
Till B, Press O
Expert Opin Biol Ther. 2009; 9(11):1407-25.
PMID: 19723016
PMC: 2776697.
DOI: 10.1517/14712590903260785.
The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation.
Tuthill M, Chen F, Paston S, De La Pena H, Rusakiewicz S, Madrigal A
Cancer Immunol Immunother. 2009; 58(9):1481-8.
PMID: 19466407
PMC: 11030108.
DOI: 10.1007/s00262-009-0722-7.